These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 10661600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Personality traits predict treatment outcome with an antidepressant in patients with functional gastrointestinal disorder.
    Tanum L, Malt UF.
    Scand J Gastroenterol; 2000 Sep; 35(9):935-41. PubMed ID: 11063152
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fenfluramine and idiopathic pain: a serotonergic study in non-psychiatric patients with functional gastrointestinal disorder.
    Tanum L, Bråtveit-Johansen K, Malt UF.
    Scand J Gastroenterol; 1998 Jul; 33(7):684-90. PubMed ID: 9712230
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression.
    Porter RJ, Mulder RT, Joyce PR.
    Psychopharmacology (Berl); 2003 Jan; 165(3):216-21. PubMed ID: 12439628
    [Abstract] [Full Text] [Related]

  • 8. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 9. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 10. Test-retest reliability of the prolactin and cortisol responses to D,L-fenfluramine challenge in disruptive behavior disorders.
    Stoff DM, Pasatiempo AP, Yeung JH, Bridger WH, Rabinovich H.
    Psychiatry Res; 1992 Apr; 42(1):65-72. PubMed ID: 1603882
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J, Toll C, Schonlau P, Rohrmann S, Netter P.
    Neuropsychobiology; 2000 Apr; 41(1):38-47. PubMed ID: 10629434
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
    Barbieri C, Magnoni V, Rauhe WG, Zanasi S, Caldara R, Ferrari C.
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB, Cowen PJ.
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 20. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J, Ryde L, Svejsø J, Lauge N, Lauritsen B, Bech P.
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.